A long-term study of 2,766 women in the Women’s Health Initiative Memory Study found that higher baseline plasma p-tau217 levels were associated with a greater risk of developing mild cognitive ...
Annual wellness visits may be critical to identify mild cognitive impairment (MCI) early among Medicare beneficiaries, which could drive more proactive care, a new study finds. The report was ...
A blood biomarker may predict women's dementia risk 25 years early, offering new prevention and monitoring opportunities, says study.
There was no significant association between menopause hormone therapy and mild cognitive impairment or dementia risk. HealthDay News — There is no evidence that menopause hormone therapy (MHT) use is ...
Lifetime risk for dementia and mild cognitive impairment (MCI) was 43% and 62%, respectively, in adults aged 55 years or older, new research showed. Additionally, the onset of MCI occurred 10 years ...
Mild cognitive impairment (MCI) is often described as being in- between normal aging and dementia, hence being “stuck in the middle”. Like dementia, cognitive decline is present, though not as severe.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results